Serum cystatin C is associated with large cerebral artery stenosis in acute ischemic stroke
Open Access
- 22 May 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (40) , 67181-67188
Abstract
Serum cystatin C is associated with large cerebral artery stenosis in acute ischemic stroke Serum cystatin C is associated with large cerebral artery stenosis in acute ischemic strokeKeywords
This publication has 41 references indexed in Scilit:
- Velocity Criteria for Intracranial Stenosis RevisitedStroke, 2011
- Cystatin C and the Risk for Cardiovascular Events in Patients With Asymptomatic Carotid AtherosclerosisStroke, 2010
- Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKDAmerican Journal of Kidney Diseases, 2008
- Cystatin C, Associated With Hemorrhagic and Ischemic Stroke, Is a Strong Predictor of the Risk of Cardiovascular Events and Death in ChineseStroke, 2007
- Serum Cystatin C for the Prediction of Glomerular Filtration Rate With Regard to the Dose Adjustment of Amikacin, Gentamicin, Tobramycin, and VancomycinTherapeutic Drug Monitoring, 2006
- Lysosomal Cysteine Proteases in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Predicting the glomerular filtration rate from serum creatinine, serum cystatin C and the Cockcroft and Gault formula with regard to drug dosage adjustmentInt. Journal of Clinical Pharmacology and Therapeutics, 2004
- Prognosis of Hypercholesterolemic Patients Taking Pravastatin for Five Years: The Chiba Lipid Intervention Program (CLIP) StudyJournal of Atherosclerosis and Thrombosis, 2002
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993